Ganymed Robotics announced that it performed a total knee arthroplasty robotic procedure without pins, markers or arrays.
The company’s integrated system has demonstrated the ability to simplify surgical workflows, shorten operating times and reduce procedural costs. This development could remove the primary barriers that have limited the adoption of robotics in high-throughput environments like Ambulatory Surgery Centers (ASCs).
To accelerate this new phase of development, Ganymed Robotics’ Board of Directors has appointed Michel Thérin, DVM, Ph.D., as Executive Chairman and Frédéric Banegas, Ph.D., as Chief Operating Officer (COO) and interim Chief Executive Officer (CEO). This follows the departure of cofounder and former CEO Sophie Cahen.
“For years, the promise of robotics in knee surgery has been hampered by the complexity and invasiveness of systems that require surgeons to drill pins into bone,” said Dr. Thérin. “We are on the cusp of delivering a solution that eliminates this fundamental challenge. I am confident in the leadership of our new team and energized by the pace of our technology progress.”
Ganymed Robotics announced that it performed a total knee arthroplasty robotic procedure without pins, markers or arrays.
The company’s integrated system has demonstrated the ability to simplify surgical workflows, shorten operating times and reduce procedural costs. This development could remove the primary barriers that have...
Ganymed Robotics announced that it performed a total knee arthroplasty robotic procedure without pins, markers or arrays.
The company’s integrated system has demonstrated the ability to simplify surgical workflows, shorten operating times and reduce procedural costs. This development could remove the primary barriers that have limited the adoption of robotics in high-throughput environments like Ambulatory Surgery Centers (ASCs).
To accelerate this new phase of development, Ganymed Robotics’ Board of Directors has appointed Michel Thérin, DVM, Ph.D., as Executive Chairman and Frédéric Banegas, Ph.D., as Chief Operating Officer (COO) and interim Chief Executive Officer (CEO). This follows the departure of cofounder and former CEO Sophie Cahen.
“For years, the promise of robotics in knee surgery has been hampered by the complexity and invasiveness of systems that require surgeons to drill pins into bone,” said Dr. Thérin. “We are on the cusp of delivering a solution that eliminates this fundamental challenge. I am confident in the leadership of our new team and energized by the pace of our technology progress.”
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
